Carealytix is a digital health company focused on transforming chronic care through user-centric technology. They provide chronic disease management solutions built for a modern world, emphasizing personalized care for individuals living with chronic conditions.

The company creates digital products to support personalized care, improve clinical workflows, and enable data-driven healthcare solutions. Their Carealytix platform offers a comprehensive, modular toolkit for managing chronic conditions, with a focus on kidney care, patient education, health tracking, data sharing, remote monitoring, and clinical trial support.

Carealytix's key products include Mizu, a personal companion app for chronic kidney disease (CKD), and Kidney+, a hybrid care program offering telecoaching, lifestyle coaching, and expert support for kidney disease patients.

The company emphasizes regulatory compliance, being a software-as-medical-device according to EU-MDR, ISO-13485 certified, and fully GDPR compliant in health data processing.

Carealytix creates value by eliminating gaps in healthcare, streamlining patient-physician interactions, enhancing clinical workflow efficiency, engaging patients in innovative ways, accelerating health research, and enabling integrated care across chronic conditions.

They partner with healthcare providers, payers, researchers, and industry to innovate and improve chronic care delivery.